PMID- 37651912 OWN - NLM STAT- MEDLINE DCOM- 20230915 LR - 20230915 IS - 1873-3573 (Electronic) IS - 0039-9140 (Linking) VI - 266 IP - Pt 2 DP - 2024 Jan 1 TI - Dual strategy for (13)C-Metabolic flux analysis of central carbon and energy metabolism in Mammalian cells based on LC-isoMRM-MS. PG - 125074 LID - S0039-9140(23)00825-1 [pii] LID - 10.1016/j.talanta.2023.125074 [doi] AB - Central carbon and energy metabolism are the most concerned metabolic pathways in (13)C-Metabolic flux analysis ((13)C-MFA). However, some alpha-keto acids, ribonucleoside triphosphate (NTPs) and deoxyribonucleoside triphosphate (dNTPs) involved in central carbon and energy metabolism pathways were unstable or reactive, leading to inaccurate metabolic flux analysis. To achieve accurate (13)C-MFA of central carbon and energy metabolism, we proposed a dual strategy for the detection of 101 metabolites in glucose metabolism pathways. N-Methylphenylethylamine (MPEA) was utilized for derivatization of 4 carboxyl (alpha-keto acids) and 8 phosphate metabolites (NTPs and dNTPs). After derivatization, the MPEA derivatives were investigated to be stable for 4 weeks under 4 degrees C and detected with high intensity in approximately 10(4) cells. On the other hand, we analyzed an additional 89 metabolites in central carbon and energy metabolic pathways were directly analyzed by liquid chromatography tandem mass spectrometry (LC-MRM-MS). The limit of detection (LODs) of our method were as low as 0.05 ng/mL and the linear range was at least two orders of magnitude with determination coefficient (R(2)) > 0.9701. The relative standard divisions (RSDs) of intra- and inter-day of 95% metabolites were below 20%. In addition, the isotope list of 82 detected metabolites in central carbon and energy metabolism were generated according to isotopologues and isotopomers for each metabolite resulting from (13)C incorporation. Accurate assessment of mass isotopomer distributions (MIDs) of intracellular (13)C-labeled metabolites was achieved in [U-(13)C]-glucose cultured HepG2 cells by our dual strategy. Finally, we performed MID analysis of 101 metabolites in central carbon and energy metabolism. Overall, this dual method is reproducible and robust for application on (13)C-MFA and has a great potential for studying clinical isotope labeled samples. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Zheng, Jie AU - Zheng J AD - Singapore Phenome Center, Nanyang Technological University, 639798, Singapore. FAU - Yang, Junjie AU - Yang J AD - School of Civil and Environmental Engineering, Nanyang Technological University, 639798, Singapore; Nanyang Environment & Water Research Institute, Nanyang Technological University, 637141, Singapore. FAU - Liang, Xu AU - Liang X AD - Singapore Phenome Center, Nanyang Technological University, 639798, Singapore. FAU - Fang, Mingliang AU - Fang M AD - School of Civil and Environmental Engineering, Nanyang Technological University, 639798, Singapore; Department of Environmental Science and Engineering, Fudan University, Shanghai, 200433, China. Electronic address: mlfang@ntu.edu.sg. FAU - Wang, Yulan AU - Wang Y AD - Singapore Phenome Center, Nanyang Technological University, 639798, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, 639798, Singapore. Electronic address: liang.xu@ntu.edu.sg. LA - eng PT - Journal Article DEP - 20230822 PL - Netherlands TA - Talanta JT - Talanta JID - 2984816R RN - NU43IAG5BC (triphosphoric acid) RN - 7440-44-0 (Carbon) RN - 0 (Keto Acids) RN - 0 (Polyphosphates) SB - IM MH - Animals MH - *Metabolic Flux Analysis MH - *Energy Metabolism MH - Carbon MH - Chromatography, Liquid MH - Keto Acids MH - Polyphosphates MH - Mammals OTO - NOTNLM OT - (13)C-metabolic flux analysis OT - Carboxyl and phosphate metabolites OT - Central carbon and energy metabolism OT - Derivatization OT - Liquid chromatography-mass spectrometry OT - Mass isotopomer distributions COIS- Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/09/01 00:41 MHDA- 2023/09/15 06:42 CRDT- 2023/08/31 18:08 PHST- 2023/06/01 00:00 [received] PHST- 2023/08/06 00:00 [revised] PHST- 2023/08/10 00:00 [accepted] PHST- 2023/09/15 06:42 [medline] PHST- 2023/09/01 00:41 [pubmed] PHST- 2023/08/31 18:08 [entrez] AID - S0039-9140(23)00825-1 [pii] AID - 10.1016/j.talanta.2023.125074 [doi] PST - ppublish SO - Talanta. 2024 Jan 1;266(Pt 2):125074. doi: 10.1016/j.talanta.2023.125074. Epub 2023 Aug 22.